Beyond dexamethasone, emerging immuno‐thrombotic therapies for COVID‐19

Understanding mechanisms underpinning hyperinflammation & coagulopathy is essential to formulating rationale therapeutic approaches beyond use of dexamethasone. Article reviews pathophysiology thought to underlie COVID‐19 with clinical correlates and therapies being investigated.

British Journal of Clinical Pharmacology